Role of NF-κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens

International Journal of Dermatology

Volumn 53, Issue 5, 2014, Pages 570-574

  Moorchung, Nikhil ^a   Kulaar, Janmeet S ^a   Chatterjee, Manas ^a   Vasudevan, Biju ^a   Tripathi, Tanu ^a   Dutta, Vibha ^a  

^a ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

NF B; Pathogenesis; Psoriasis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL; DERMIS; DISEASE SEVERITY; EPIDERMIS CELL; EPIDERMIS HYPERPLASIA; FEMALE; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY INFILTRATE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PSORIASIS; SKIN BIOPSY; STAINING; BIOPSY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SKIN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; PROSPECTIVE STUDIES; PSORIASIS; SKIN; STAINING AND LABELING; YOUNG ADULT;

EID: 84899484901     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12050     Document Type: Article

References (26)

1. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
2. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141-179.
3. Lawrence T, Gilroy DW, Colville-Nash PR, et al. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 2001; 7: 1291-1297.
4. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866.
5. Kawashima K, Doi H, Ito Y, et al. Evaluation of cell death and proliferation in psoriatic epidermis. J Dermatol Sci 2004; 35: 207-214.
6. Das RP, Jain AK, Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian J Dermatol 2009; 54: 7-12.
7. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999; 38: 241-251.
8. Vestergaard C, Johansen C, Otkjaer K, et al. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine 2005; 29: 49-55.
9. Chen F, Castronova V, Shi X, et al. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7-17.
10. Barnes PJ, Karin M. Nuclear factor-kappa B. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
11. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF kappa B. Annu Rev Cell Biol 1994; 10: 405-455.
12. Sonenshein GE. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol 1997; 8: 113-119.
13. Tak PP, Firestein GS. NF-kB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11.
14. Jordan CT, Cao Li, Roberson EDO, et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet 2012; 90: 784-795.
15. Takada Y, Singh S, Aggarwal BB. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappa B-mediated gene expression and up-regulation of apoptosis. J Biol Chem 2004; 279: 15096-15104.
16. Doger FK, Dikicioglu E, Ergin F, et al. Nature of cell kinetics in psoriatic epidermis. J Cutan Pathol 2007; 34: 257-263.
17. Moorchung N, Srivastava AN, Sharma AK, et al. Nuclear factor kappa-B and histopathology of chronic gastritis. Indian J Pathol Microbiol 2010; 53: 418-421.
18. Han ZN, Boyle DL, Manning AM, et al. AP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collageninduced arthritis. Autoimmunity 1998; 28: 197-208.
19. Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004; 279: 32633-32642.
20. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46: 1-23.
21. Lizzul PF, Aphale A, Malaviya R, et al. Differential expression of phosphorylated NF-jB/RelA in normal and psoriatic epidermis and downregulation of NF-κB in response to treatment with etanercept. J Invest Dermatol 2005; 124: 1275-1283.
22. Paul AT, Gohil VM, Bhutani KK. Modulating TNF-alpha signaling with natural products. Drug Discov Today 2006; 11: 725-732.
23. Cumberbatch M, Singh M, Dearman RJ, et al. Impaired Langerhans cell migration in psoriasis. J Exp Med 2006; 203: 953-960.
24. Tsuruta D. NF-κB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 2009; 3: 40-48.
25. Abdou AG, Hanout HM. Evaluation of survivin and NF-kB in psoriasis, an immunohistochemical study. J Cutan Pathol 2008; 35: 445-451.
26. Moorchung N, Kulaar JS, Chatterjee M, et al. The histopathology of psoriasis. Indian J Dermatol (in press).